These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 3970930

  • 21. Endogenous ADP-ribosylation of elongation factor 2 in polyribosome fraction of rabbit reticulocytes.
    Sitikov AS, Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1984 Oct 15; 176(1):261-3. PubMed ID: 6092136
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 23. Interaction of phosphorylated elongation factor EF-2 with nucleotides and ribosomes.
    Dumont-Miscopein A, Lavergne JP, Guillot D, Sontag B, Reboud JP.
    FEBS Lett; 1994 Dec 19; 356(2-3):283-6. PubMed ID: 7805855
    [Abstract] [Full Text] [Related]

  • 24. Crystal structure of ADP-ribosylated ribosomal translocase from Saccharomyces cerevisiae.
    Jørgensen R, Yates SP, Teal DJ, Nilsson J, Prentice GA, Merrill AR, Andersen GR.
    J Biol Chem; 2004 Oct 29; 279(44):45919-25. PubMed ID: 15316019
    [Abstract] [Full Text] [Related]

  • 25. Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome.
    Susorov D, Zakharov N, Shuvalova E, Ivanov A, Egorova T, Shuvalov A, Shatsky IN, Alkalaeva E.
    J Biol Chem; 2018 Apr 06; 293(14):5220-5229. PubMed ID: 29453282
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
    Ahuja D, Vera MD, SirDeshpande BV, Morimoto H, Williams PG, Joullié MM, Toogood PL.
    Biochemistry; 2000 Apr 18; 39(15):4339-46. PubMed ID: 10757982
    [Abstract] [Full Text] [Related]

  • 27. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
    Nurten R, Albeniz I, Bermek E.
    IUBMB Life; 1999 Nov 18; 48(5):557-62. PubMed ID: 10637774
    [Abstract] [Full Text] [Related]

  • 28. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR, Huang K, Wilson BA, Papini E, Covacci A, Collier RJ.
    Biochemistry; 1994 May 03; 33(17):5155-61. PubMed ID: 8172890
    [Abstract] [Full Text] [Related]

  • 29. Reduced puromycin sensitivity of translocated polysomes after the addition of elongation factor 2 and non-hydrolysable GTP analogues.
    Nilsson L, Nygård O.
    FEBS Lett; 1992 Aug 31; 309(1):89-91. PubMed ID: 1511751
    [Abstract] [Full Text] [Related]

  • 30. Affinity labelling of the eukaryotic elongation factor EF-2 with the guanosine nucleotide analogue 5'-p-fluorosulfonylbenzoylguanosine.
    Nilsson L, Nygård O.
    Biochim Biophys Acta; 1984 May 15; 782(1):49-54. PubMed ID: 6722159
    [Abstract] [Full Text] [Related]

  • 31. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
    Chung DW, Collier RJ.
    Biochim Biophys Acta; 1977 Aug 11; 483(2):248-57. PubMed ID: 196649
    [Abstract] [Full Text] [Related]

  • 32. Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.
    Nairn AC, Palfrey HC.
    J Biol Chem; 1987 Dec 25; 262(36):17299-303. PubMed ID: 3693353
    [Abstract] [Full Text] [Related]

  • 33. Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties.
    Bodley JW, Dunlop PC, VanNess BG.
    Methods Enzymol; 1984 Dec 25; 106():378-87. PubMed ID: 6387379
    [No Abstract] [Full Text] [Related]

  • 34. Structural and functional studies of the interaction of the eukaryotic elongation factor EF-2 with GTP and ribosomes.
    Nilsson L, Nygård O.
    Eur J Biochem; 1988 Jan 15; 171(1-2):293-9. PubMed ID: 3338467
    [Abstract] [Full Text] [Related]

  • 35. Characterisation of the ribosomal binding site for eukaryotic elongation factor 2 by chemical cross-linking.
    Nygård O, Nilsson L, Westermann P.
    Biochim Biophys Acta; 1987 Dec 08; 910(3):245-53. PubMed ID: 3676324
    [Abstract] [Full Text] [Related]

  • 36. Binding of aminoacyl-tRNA to ribosomes promoted by elongation factor Tu. Studies on the role of GTP hydrolysis.
    Yokosawa H, Kawakita M, Arai K, Inoue-Yokosawa N, Kaziro Y.
    J Biochem; 1975 Apr 08; 77(4):719-28. PubMed ID: 1097432
    [Abstract] [Full Text] [Related]

  • 37. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O, Ozdemirli M, Nurten R, Bermek E.
    Biochem Biophys Res Commun; 1986 Sep 30; 139(3):1210-4. PubMed ID: 3094526
    [Abstract] [Full Text] [Related]

  • 38. Cholera toxin action on rabbit corpus luteum membranes: effects on adenylyl cyclase activity and adenosine diphospho-ribosylation of the stimulatory guanine nucleotide-binding regulatory component.
    Abramowitz J, Campbell AR.
    Biol Reprod; 1985 Mar 30; 32(2):463-74. PubMed ID: 3921075
    [Abstract] [Full Text] [Related]

  • 39. Primary structure of elongation factor 2 around the site of ADP-ribosylation is highly conserved from archaebacteria to eukaryotes.
    Gehrmann R, Henschen A, Klink F.
    FEBS Lett; 1985 Jun 03; 185(1):37-42. PubMed ID: 3996598
    [Abstract] [Full Text] [Related]

  • 40. The pretranslocation ribosome is targeted by GTP-bound EF-G in partially activated form.
    Hauryliuk V, Mitkevich VA, Eliseeva NA, Petrushanko IY, Ehrenberg M, Makarov AA.
    Proc Natl Acad Sci U S A; 2008 Oct 14; 105(41):15678-83. PubMed ID: 18836081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.